Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
ConditionProstate Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorUniversity of Southern California
About this trial
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Men of all racial and ethnic groups 18 years of age or older
Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
Prior participation on clinical trials is allowed
Disqualifiers
Inability to give informed consent
Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer
Trial population
Adult men diagnosed with advanced (metastatic) prostate cancer at Norris Comprehensive Cancer Center and Los Angeles General Medical Center with either metastatic castrate sensitive prostate cancer (mCSPC) or metastatic castration-resistant prostate cancer (mCRPC).
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Non-Interventional Study
Other interventionNon-interventional study
Treatment groups
300 Participants
are divided into 1 treatment groupGroup A: Observational1 intervention
Trial outcomes
Primary outcomes
1
Collection of biological specimens and clinical data for future research related to prostate cancer.
The objective of this study is to create a biorepository of biospecimen and clinical data. There is no primary clinical outcome for this study.
Time frame
Up to 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Southern California
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov